BioSpace News Archive

Business

Ipsen and BioLabs to open new Innovation Center in Cambridge (U.S.) to foster development of new therapies for patients

Ipsen Innovation Center – BioLabs to be located in Ipsen’s new and third global hub in the heart of Cambridge, Massachusetts

July 19, 2018
·
8 min read
Drug Development

New Phase 3 Data Show Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis

Data to be discussed with global health authorities, including the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)

July 19, 2018
·
12 min read
Drug Development

Innovative Alzheimer’s Treatment from China Concludes Phase 3 Clinical Trials

Green Valley plans to submit the application for treatment to the China National Drug Administration this Year

July 19, 2018
·
1 min read
BioMidwest

SURVEY: Progress on Patient Safety Slowed by Ineffective Technology, Healthcare Professionals Say

Nearly nine out of 10 respondents to a national survey of physicians, nurses and healthcare executives say their organizations are successfully improving the safety of patients.

July 19, 2018
·
7 min read
Business

Eyecarrot Secures Distribution Deal With Australasia’s Leading Behavioral Optometric Organization ACBO (‘Australasian College of Behavioural Optometrists’)

Eyecarrot Innovations Corp is pleased to announce it has secured a distribution deal with the leading Australasian Behavioural Optometric group ACBO

July 19, 2018
·
3 min read
Business

VA and IBM Watson Health Extend Partnership to Support Veterans With Cancer

The U.S. Department of Veterans Affairs (VA) and IBM Watson Health (NYSE: IBM) announced the extension of a public-private partnership to apply artificial intelligence (AI) to help interpret cancer data in the treatment of Veteran patients.

July 19, 2018
·
2 min read
Pharm Country

Boehringer Ingelheim and Lilly announce Tradjenta’s CARMELINA® cardiovascular outcome trial meets primary endpoint

Study supports long-term cardiovascular safety of Tradjenta® (linagliptin) in adults with type 2 diabetes

July 19, 2018
·
12 min read
Business

Leafbuyer Technologies Inc. Continues Strong Sales Growth

The company has announced a 50% sales increase from 4th Quarter 2017 compared to 4th Quarter 2018. June 2018 was the strongest sales growth in company history

July 19, 2018
·
1 min read
Business

Enzyvant Announces Collaboration with PerkinElmer to Enable Diagnostic Testing for Farber Disease

Enzyvant announced that it has formed a collaboration with PerkinElmer Genomics, a global genomic testing company.

July 19, 2018
·
2 min read